在美国诊断的基本震的流行:基于行政索赔的研究
Junji Lin1, Rajesh Pahwa2, Elan D Louis3
1Jazz Pharmaceuticals, Palo Alto, CA, USA.
Tremor and other hyperkinetic movements (New York, N.Y.)
|October 27, 2025
概括
基本震 (ET) 影响超过一百万美国成年人,患病率因年龄而异. 准确的病例定义和标准化对于在现实数据中可靠的基本震患病率估计至关重要.
科学领域:
- 神经学 神经学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 基本震 (ET) 是一种普遍存在的运动障碍,患病率估计差异很大.
- 由于方法因素,以前的研究在准确确定ET患病率方面遇到了挑战.
研究的目的:
- 为了估计在美国成年人中诊断的基本震 (ET) 的患病率.
- 评估病例定义和标准化对ET患病率估计的影响.
主要方法:
- 利用了美国成人索赔数据 (2016-2022) 的MerativeTM MarketScan®研究数据库.
- 在12个月内通过≥2个索赔确定ET诊断.
- 使用2024年美国人口数据计算年龄标准化流行率.
主要成果:
- 未调整的患病率为0.28%,随着年龄的增长而增加 (从18-40岁的0.06%到≥75岁的1.61%).
- 年龄标准化患病率达到0.42%,估计在2024年有110万美国成年人被诊断患有ET.
- 一个更敏感的病例定义将估计的患病率几乎翻了一番,达到210万成年人.
结论:
- 基本震影响了美国成年人口的很大一部分.
- 适当的病例定义和标准化对于使用现实数据准确估计慢性疾病的患病率至关重要.
相关概念视频
Prevalence and Incidence
1.5K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.5K
Seizures: Classification
1.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Therapeutic Drug Monitoring: Affecting Factors
196
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
196
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
806
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
806
Generalized Anxiety Disorder
621
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
621


